Avandia Diabetes Drug: New FDA Restrictions, Type 2 Diabetes

Photos

Avandia Diabetes Drug

see larger image

uploaded by Getty Images

GlaxoSmithKline Avandia Diabetes Drug, FDA Imposes New Restrictions To Patients With Type 2 Diabetes

The Food And Drug Administration says Avandia can stay on the market in the USA but it outlined new restrictions.

• Avandia FDA Review
• Avandia Report Released
• More Avandia coverage
  

Avanida came under FDA review after it was connected to risks of causing heart attacks.

Meanwhile the FDA's European equivalent, the European Medicines Agency (EMA) said Avandia should be removed from the market completely. Banning Avandia from sale in Europe will require the approval of the the European Commission  (EU).